Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Toshihiko Aranishi
Observed names:
T Aranishi,
T. Aranishi,
Toshihiko ARANISHI
Institutions:
Juntendo University,
Eli Lilly (Japan)
Observed institutions:
Kyoto University,
Juntendo University,
Eli Lilly (Japan),
Shikoku Cancer Center,
Public Health Research Foundation,
University of Marketing and Distribution Sciences,
Nagoya University,
The University of Tokyo
show all 8
ORCID:
0000-0001-8862-9468
Observed ORCID:
0000-0001-8862-9468
OpenAlex ID:
A5091269284
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
2009
·
Kojiro Shimozuma
, Yasuo Ohashi
, et al.
·
Supportive Care in Cancer
·
215
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial
2012
·
Kojiro Shimozuma
, Yasuo Ohashi
, et al.
·
Supportive Care in Cancer
·
106
Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)
2008
·
Katsumasa Kuroi
, Kojiro Shimozuma
, et al.
·
Supportive Care in Cancer
·
58
A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer
2008
·
K. Kuroi
, K. Shimozuma
, et al.
·
Japanese Journal of Clinical Oncology
·
41
Patient and physician perspectives on alopecia areata: A real‐world assessment of severity and burden in Japan
2022
·
Emily Edson‐Heredia
, Toshihiko Aranishi
, et al.
·
The Journal of Dermatology
·
31
Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample
2022
·
Toshihiko Aranishi
, Taisuke Ito
, et al.
·
The Journal of Dermatology
·
27
PDF
Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)
2020
·
Yasushi Ishigaki
, Alena Strizek
, et al.
·
Diabetes Therapy
·
21
PDF
Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site
2019
·
Toshihiko Aranishi
, Yukiko Nagai
, et al.
·
Diabetes Therapy
·
16
PDF
Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study
2023
·
Chaochen Wang
, Hitoe Torisu-Itakura
, et al.
·
Journal of Dermatological Treatment
·
15
PDF
Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patients
2022
·
Hiroto Tsuboi
, Yuko Kaneko
, et al.
·
Current Medical Research and Opinion
·
8
PDF
Evaluation of treatment satisfaction misalignment between Japanese psoriasis patients and their physicians – Japanese psoriasis patients and their physicians do not share the same treatment satisfaction levels
2021
·
Yukari Okubo
, Hitoe Torisu-Itakura
, et al.
·
Current Medical Research and Opinion
·
8
Cross-sectional survey in patients with type 1 and type 2 diabetes to understand mealtime insulin unmet needs in Japan: The MINUTES-J study
2020
·
Hitoshi Ishii
, Suzuki Shuichi
, et al.
·
Diabetes Research and Clinical Practice
·
8
Comparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch® among self-injection-naïve patients with type 2 diabetes mellitus in Japan
2018
·
Toshinari Asakura
, Shuichi Suzuki
, et al.
·
Current Medical Research and Opinion
·
8
PDF
Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan
2022
·
Chaochen Wang
, Toshihiko Aranishi
, et al.
·
Dermatology and Therapy
·
7
PDF
Assessment and quantification of taxane-induced neurotoxicity in a phase III randomized trial of breast cancer (AC followed by PAC/DOC vs. PAC/DOC alone): N-SAS BC 02
2006
·
K. Shimozuma
, Y. Ohashi
, et al.
·
Journal of Clinical Oncology
·
7
Cost-effectiveness in perioperative therapy in the era of immune checkpoint inhibitors.
2024
·
Masahiro Fujioka
, Toshihiko Aranishi
, et al.
·
Journal of Clinical Oncology
·
4
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan
2024
·
Toshihiko Aranishi
, Ataru Igarashi
, et al.
·
Diabetes Therapy
·
2
PDF
HTA119 Methodological Issues in Health Technology Assessment (HTA) for Re-Pricing in Japan
2022
·
A Igarashi
, T Aranishi
, et al.
·
Value in Health
·
1
PDF
Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
2022
·
Yutaka SHIMOMURA
, Taisuke ITO
, et al.
·
The Nishinihon Journal of Dermatology
·
1
PDF
Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus – a post-hoc analysis
2020
·
Toshinari Asakura
, Toshinobu Yamazaki
, et al.
·
Current Medical Research and Opinion
·
1
PDF
Impact of high body mass index on health state utilities: a time trade-off study in the general population of Japan
2026
·
Tomohiro Tanaka
, Hideaki Kagitani
, et al.
·
Journal of Medical Economics
PDF
Medical costs attributable to obesity and obesity-related health disorders in a Japanese population using JMDC claims database
2026
·
Taisuke Kojima
, Satoshi Osaga
, et al.
·
Journal of Medical Economics
Cost-Effectiveness of Perioperative Immune Checkpoint Therapy for NSCLC in Japan, the United States, and Brazil
2026
·
Masahiro Fujioka
, Toshihiko Aranishi
, et al.
·
JTO Clinical and Research Reports
PDF
Correction to: The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan
2025
·
Toshihiko Aranishi
, Ataru Igarashi
, et al.
·
Diabetes Therapy
PDF
611P Cost-effectiveness of perioperative ICI therapy with NSCLC in Japan, USA, Brazil
2024
·
T. Aranishi
, M. Fujioka
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
27
Citation count:
585
H-index:
9
I10-index:
9
Year
Topic
Type